A pragmatic natriuresis-guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure ...

Amsterdam, Netherlands – 28 Aug 2023: A pragmatic natriuresis guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting all-cause ...

NATIONAL HARBOR, Md. -- In acute heart failure (AHF), salt supplementation during aggressive diuretic therapy didn't appear to mitigate neurohormonal activation in a randomized placebo-controlled ...

Please provide your email address to receive an email when new articles are posted on . Diuretics in combination with renin-angiotensin system inhibitors may slow chronic kidney disease on top of ...

MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development-stage company pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart ...

Hand opening pill bottle Clearer guidelines for diuretic management in patients with chronic kidney disease are needed, according to investigators. Adding diuretics rather than calcium channel ...

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...

Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual ...

Semaglutide — a type of medication used to treat diabetes and can help with weight loss — reduces the need for loop diuretics and dose, and has positive effects on heart failure symptoms, physical ...

Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...

Please provide your email address to receive an email when new articles are posted on . Mortality risk nearly doubled for patients who developed hyponatremia soon after initiating a thiazide vs.

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)12 was a randomized controlled study of 45,000 persons with hypertension (BP >140/90) and one additional risk ...